Vertex Completes $10 Billion Crinetics Acquisition, Expands Executive Leadership Team

Vertex Pharmaceuticals has completed its approximately $10 billion acquisition of Crinetics Pharmaceuticals, adding a commercial endocrine therapy and late-stage clinical... Read More

The post Vertex Completes $10 Billion Crinetics Acquisition, Expands Executive Leadership Team appeared first on citybiz.